PURE BIOSCIENCE, INC. (PURE)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 07-31. Amounts in USD.

Revenue TTM

0 3M 6M 9M Q4 '11: 464K Q1 '12: 697K Q2 '12: 850K Q3 '12: 929K Q4 '12: 812K Q4 '18: 1.8M Q1 '19: 1.9M Q2 '19: 1.9M Q3 '19: 1.8M Q4 '19: 1.9M Q1 '20: 1.7M Q2 '20: 1.7M Q3 '20: 3.6M Q4 '20: 6.9M Q1 '21: 8.1M Q2 '21: 8.7M Q3 '21: 7M Q4 '21: 3.9M Q1 '22: 2.8M Q2 '22: 2.3M Q3 '22: 2.3M Q4 '22: 1.9M Q1 '23: 1.8M Q2 '23: 1.8M Q3 '23: 1.7M Q4 '23: 1.9M Q1 '24: 2.1M Q2 '24: 2.1M Q3 '24: 2.1M Q4 '24: 2M Q1 '25: 1.8M Q2 '25: 1.9M Q3 '25: 1.9M Q4 '25: 2.2M Q1 '26: 2.4M Q2 '26: 2.4M Q3 '26: 2.4M Q1 '12 Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Gross Profit TTM

0 2M 4M 6M Q4 '20: 4M Q1 '21: 4.7M Q2 '21: 5.1M Q3 '21: 4.1M Q4 '21: 2.1M Q1 '22: 1.5M Q2 '22: 1.1M Q3 '22: 1.1M Q4 '22: 1M Q1 '23: 928K Q2 '23: 891K Q3 '23: 762K Q4 '23: 971K Q1 '24: 1.2M Q2 '24: 1.1M Q3 '24: 1.2M Q4 '24: 1.2M Q1 '25: 1M Q2 '25: 1.1M Q3 '25: 1.1M Q4 '25: 1.3M Q1 '26: 1.4M Q2 '26: 1.4M Q3 '26: 1.4M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Operating Income TTM

-15M -10M -5M 0 5M 10M 15M Q4 '11: -8.4M Q1 '12: -8.7M Q2 '12: -8.4M Q3 '12: -8.4M Q4 '12: -8.8M Q1 '13: -8.2M Q2 '13: -7.8M Q3 '13: -7.6M Q4 '13: -7.3M Q1 '14: -9.4M Q2 '14: -10.8M Q3 '14: -11.4M Q4 '14: -11.9M Q1 '15: -10M Q2 '15: -8.5M Q3 '15: -8.4M Q4 '15: -7.6M Q1 '16: -7.6M Q2 '16: -8.1M Q3 '16: -7.5M Q4 '16: -7.1M Q1 '17: -6.8M Q2 '17: -5.9M Q3 '17: -6M Q4 '17: -6M Q1 '18: -6.3M Q2 '18: -7M Q3 '18: -7.1M Q4 '18: -7M Q1 '19: -7.7M Q2 '19: -6.9M Q3 '19: -6.1M Q4 '19: -5.6M Q1 '20: -4.2M Q2 '20: -3.5M Q3 '20: -2.1M Q4 '20: 4K Q1 '21: 955K Q2 '21: 1M Q3 '21: -260K Q4 '21: -2.3M Q1 '22: -2.9M Q2 '22: -3.3M Q3 '22: -3.2M Q4 '22: -3.7M Q1 '23: -3.9M Q2 '23: -4M Q3 '23: -4.1M Q4 '23: -3.9M Q1 '24: -3.7M Q2 '24: -3.6M Q3 '24: -3.5M Q4 '24: -3.2M Q1 '25: -3.1M Q2 '25: -2.9M Q3 '25: -2.6M Q4 '25: -2.3M Q1 '26: -2M Q2 '26: -2M Q3 '26: -1.9M Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

Net Income TTM

-21M -14M -7M 0 7M 14M 21M Q4 '11: -8.4M Q1 '12: -8.7M Q2 '12: -8.4M Q3 '12: -8.4M Q4 '12: -8.9M Q1 '13: -8.7M Q2 '13: -8.3M Q3 '13: -8M Q4 '13: -7.7M Q1 '14: -9.4M Q2 '14: -10M Q3 '14: -10.5M Q4 '14: -11.1M Q1 '15: -9.1M Q2 '15: -8.4M Q3 '15: -8.4M Q4 '15: -7.6M Q1 '16: -8.5M Q2 '16: -17.7M Q3 '16: -15.6M Q4 '16: -14.4M Q1 '17: -13.3M Q2 '17: -3.3M Q3 '17: -5.1M Q4 '17: -6.3M Q1 '18: -6.9M Q2 '18: -8M Q3 '18: -7.9M Q4 '18: -7.4M Q1 '19: -7.7M Q2 '19: -6.9M Q3 '19: -7.1M Q4 '19: -6.6M Q1 '20: -5.1M Q2 '20: -4.5M Q3 '20: -2.1M Q4 '20: 4K Q1 '21: 949K Q2 '21: 1M Q3 '21: -264K Q4 '21: -2.3M Q1 '22: -2.9M Q2 '22: -3M Q3 '22: -3M Q4 '22: -3.5M Q1 '23: -3.7M Q2 '23: -4M Q3 '23: -4.2M Q4 '23: -4M Q1 '24: -3.7M Q2 '24: -3.6M Q3 '24: -3.6M Q4 '24: -3.4M Q1 '25: -3.3M Q2 '25: -3.1M Q3 '25: -2.8M Q4 '25: -2.4M Q1 '26: -2.2M Q2 '26: -2.2M Q3 '26: -2.2M Q3 '12 Q3 '14 Q3 '16 Q3 '18 Q3 '20 Q3 '22 Q3 '24 Q3 '26

Cost of Revenue TTM

0 1.5M 3M 4.5M Q2 '18: 668K Q3 '18: 702K Q4 '18: 763K Q1 '19: 820K Q2 '19: 819K Q3 '19: 770K Q4 '19: 728K Q1 '20: 681K Q2 '20: 663K Q3 '20: 1.5M Q4 '20: 2.9M Q1 '21: 3.4M Q2 '21: 3.6M Q3 '21: 2.9M Q4 '21: 1.9M Q1 '22: 1.4M Q2 '22: 1.2M Q3 '22: 1.2M Q4 '22: 853K Q1 '23: 895K Q2 '23: 913K Q3 '23: 925K Q4 '23: 906K Q1 '24: 972K Q2 '24: 921K Q3 '24: 893K Q4 '24: 811K Q1 '25: 762K Q2 '25: 777K Q3 '25: 802K Q4 '25: 899K Q1 '26: 926K Q2 '26: 968K Q3 '26: 997K Q1 '19 Q2 '20 Q3 '21 Q4 '22 Q1 '24 Q2 '25 Q3 '26

Operating Cash Flow TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q4 '11: -6.1M Q1 '12: -6.4M Q2 '12: -5.7M Q3 '12: -5.5M Q4 '12: -5.6M Q1 '13: -5.3M Q2 '13: -5.5M Q3 '13: -5.1M Q4 '13: -3.9M Q1 '14: -4.9M Q2 '14: -5.2M Q3 '14: -5.8M Q4 '14: -6.3M Q1 '15: -6.3M Q2 '15: -5.8M Q3 '15: -5.8M Q4 '15: -6.1M Q1 '16: -5.1M Q2 '16: -5M Q3 '16: -4.9M Q4 '16: -5M Q1 '17: -4.8M Q2 '17: -4.8M Q3 '17: -4.7M Q4 '17: -4.6M Q1 '18: -4.5M Q2 '18: -4.5M Q3 '18: -4.4M Q4 '18: -3.9M Q1 '19: -3.9M Q2 '19: -3.3M Q3 '19: -3M Q4 '19: -3M Q1 '20: -2.3M Q2 '20: -2.4M Q3 '20: -1.8M Q4 '21: -1.2M Q1 '22: -1.5M Q2 '22: -2M Q3 '22: -2.2M Q4 '22: -2.4M Q1 '23: -2.7M Q2 '23: -3.1M Q3 '23: -3.1M Q4 '23: -3.3M Q1 '24: -2.8M Q2 '24: -2.7M Q3 '24: -2.7M Q4 '24: -2.5M Q1 '25: -2.6M Q2 '25: -2.3M Q3 '25: -2.2M Q4 '25: -2M Q1 '26: -1.8M Q2 '26: -1.8M Q3 '26: -1.8M Q2 '13 Q1 '15 Q4 '16 Q3 '18 Q2 '20 Q1 '23 Q4 '24 Q3 '26

Free Cash Flow TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q2 '12: -5.7M Q3 '12: -5.5M Q4 '12: -5.6M Q1 '13: -5.4M Q2 '13: -5.6M Q3 '13: -5.1M Q4 '13: -3.9M Q1 '14: -4.9M Q2 '14: -5.2M Q3 '14: -5.8M Q4 '14: -6.3M Q2 '17: -5.2M Q3 '17: -4.9M Q4 '17: -4.8M Q1 '18: -4.7M Q2 '18: -4.5M Q3 '18: -4.4M Q4 '18: -3.9M Q1 '19: -3.9M Q2 '19: -3.3M Q3 '19: -3M Q4 '19: -3M Q4 '21: -1.7M Q1 '22: -1.9M Q2 '22: -2M Q3 '22: -2.3M Q4 '22: -2.5M Q1 '23: -2.8M Q2 '23: -3.1M Q3 '23: -3.2M Q4 '23: -3.3M Q4 '12 Q4 '13 Q4 '14 Q1 '18 Q1 '19 Q4 '21 Q4 '22 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q3 '15: 40.8M Q3 '16: 71.3M Q3 '17: 62.7M Q3 '19: 76.6M Q3 '20: 85.7M Q3 '21: 87.2M Q1 '22: 87.4M Q2 '22: 87.9M Q3 '22: 87.9M Q1 '23: 111.4M Q2 '23: 111.4M Q3 '23: 111.4M Q1 '24: 111.9M Q2 '24: 111.9M Q3 '24: 111.9M Q1 '25: 111.9M Q2 '25: 111.9M Q3 '25: 111.9M Q1 '26: 111.9M Q2 '26: 111.9M Q3 '26: 110.8M Q3 '17 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3.00 -2.00 -1.00 0.00 1.00 2.00 3.00 Q4 '11: -1.80 Q1 '12: -2.21 Q2 '12: -2.55 Q3 '12: -2.81 Q4 '12: -1.59 Q1 '13: -1.37 Q2 '13: -1.13 Q3 '13: -0.96 Q4 '13: -0.74 Q1 '14: -0.68 Q2 '14: -0.61 Q3 '14: -0.54 Q4 '14: -0.45 Q1 '15: -0.31 Q2 '15: -0.25 Q3 '15: -0.23 Q4 '15: -0.18 Q1 '16: -0.20 Q2 '16: -0.35 Q3 '17: -0.04 Q4 '17: -0.10 Q1 '18: -0.11 Q2 '18: -0.13 Q3 '18: -0.12 Q4 '18: -0.11 Q1 '19: -0.11 Q2 '19: -0.10 Q3 '19: -0.11 Q4 '19: -0.10 Q1 '20: -0.07 Q2 '20: -0.06 Q3 '20: -0.02 Q4 '20: 0.00 Q1 '21: 0.01 Q2 '21: 0.01 Q3 '21: -0.01 Q4 '21: -0.03 Q1 '22: -0.04 Q2 '22: -0.04 Q3 '22: -0.04 Q4 '22: -0.04 Q1 '23: -0.04 Q2 '23: -0.05 Q3 '23: -0.05 Q4 '23: -0.05 Q1 '24: -0.05 Q2 '24: -0.04 Q3 '24: -0.04 Q4 '24: -0.03 Q1 '25: -0.03 Q2 '25: -0.03 Q3 '25: -0.03 Q4 '25: -0.03 Q1 '26: -0.02 Q2 '26: -0.02 Q3 '26: -0.02 Q2 '13 Q1 '15 Q4 '17 Q3 '19 Q2 '21 Q1 '23 Q4 '24 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.